A new EUR 6 million research project (NEPHSTROM) has been funded by the European Union Horizon 2020 programme to evaluate the clinical safety and efficacy of a next-generation cell therapy discovered by Galway-based Orbsen Therapeutics, to combat diabetic kidney disease.
from EUROPA - Syndicated Research News Feed http://ift.tt/1GVt2Ho
via IFTTT
No comments:
Post a Comment